Sep 19 2026 10:58 AM EST

Nomad Foods Raises FY 2026 EPS Guidance After Revenue Dip, Shares Edge Lower

Nomad Foods (NASDAQ: NOMD) disclosed on 7 May 2026 that it would raise its full‑year adjusted EPS guidance to a range of $1.59‑$1.76, even though FY 2025 revenue fell 5.9% and net profit slipped 12% year‑over‑year. The announcement coincided with a 3.2% decline in the stock over the past five trading days, reflecting investor concern over margin compression and higher transformation‑related costs.

For FY 2025 the company reported revenue of $3.03 billion, down 2.2% YoY, and net income of $136.7 million, a decline of 39.8% from the prior year. Adjusted EBITDA margin contracted to 17.2% from 18.2%, while gross margin slipped to roughly 27.5% versus 29.6% a year earlier. Exceptional and restructuring expenses rose to $78.4 million, up from $69.5 million in 2024.

Transformation Programme Drives Cost Structure

The company’s multi‑year value‑creation plan, announced on 13 Aug 2026, targets supply‑chain optimisation, factory closures (including the Sweden site), SKU rationalisation, automation and data‑integration. While the initiative is intended to deliver long‑term productivity gains, the short‑term impact is evident in higher restructuring costs and a temporary dip in operating margins. The 2025‑2026 trailing‑12‑month operating margin fell from 13.3% to 12.7%.

Guidance and Capital Allocation

Management’s decision to lift the adjusted EPS outlook to $1.59‑$1.76 reflects confidence that the productivity uplift from the transformation programme will offset the current margin headwinds. The firm continues a disciplined capital‑return policy, having deployed roughly $219 million of a $500 million share‑buyback programme and maintaining a quarterly dividend of $0.17 per share. Liquidity remains solid with cash of $324.8 million and an unused revolver of $175 million.

Macro‑Economic Context

The European frozen‑foods market faces inflationary pressure from higher labour, energy and transport costs, which imposed an estimated 350 bps drag on gross margin. Productivity initiatives have mitigated roughly half of this impact, contributing a +190 bps offset. Currency volatility—particularly GBP/EUR/USD movements—also influences reported results, prompting the EPS guidance to be tied to the 6 Aug 2026 FX rates. Additionally, Brexit‑related trade frictions and lingering energy‑price volatility linked to the Ukraine conflict add to cost uncertainty.

Risks and Outlook

Investors should monitor the pace at which the transformation programme translates into margin recovery. Persistent inflation, potential escalation of energy prices, and ongoing Brexit‑related supply‑chain disruptions could further erode profitability. The elevated restructuring expense base, while expected to decline, adds uncertainty to near‑term earnings visibility. Finally, the company’s reliance on a branded portfolio of legacy names—Bird’s Eye, Findus, iglo and Ledo/Frikom—means that any shift in consumer preferences toward fresh or alternative protein categories could impact growth.